[go: up one dir, main page]

TR200101709T2 - İltihabik hastalıkların tedavisinde yararlı olan bileşikler - Google Patents

İltihabik hastalıkların tedavisinde yararlı olan bileşikler

Info

Publication number
TR200101709T2
TR200101709T2 TR2001/01709T TR200101709T TR200101709T2 TR 200101709 T2 TR200101709 T2 TR 200101709T2 TR 2001/01709 T TR2001/01709 T TR 2001/01709T TR 200101709 T TR200101709 T TR 200101709T TR 200101709 T2 TR200101709 T2 TR 200101709T2
Authority
TR
Turkey
Prior art keywords
treatment
inflammatory diseases
compounds useful
compounds
processes
Prior art date
Application number
TR2001/01709T
Other languages
English (en)
Inventor
Robert Armour Duncan
Brown David
Stuart Congreave Miles
Martin Gore Paul
Victor Steven Green Darren
Holman Stuart
Iain Maclean Jack Torquil
Philip Keeling Steven
Mcmurtrie Mason Andrew
Morriss Karen
Grahame Ramsden Nigel
Ward Peter
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of TR200101709T2 publication Critical patent/TR200101709T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Bulusa göre yeni formül (I) bilesikleri, ki burada R1, R2, R3, R4, R5 ve R6 tarifnamede tanimlandigi gibidir, bunlarin hazirlanmasi için islemler, bunlari içeren formülasyonlar ve bunlarin iltihabik hastaliklarin tedavisinde kullanimlari saglanmaktadir.
TR2001/01709T 1998-12-18 1999-12-16 İltihabik hastalıkların tedavisinde yararlı olan bileşikler TR200101709T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9828074.6A GB9828074D0 (en) 1998-12-18 1998-12-18 Therapeutically useful compounds

Publications (1)

Publication Number Publication Date
TR200101709T2 true TR200101709T2 (tr) 2001-12-21

Family

ID=10844608

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01709T TR200101709T2 (tr) 1998-12-18 1999-12-16 İltihabik hastalıkların tedavisinde yararlı olan bileşikler

Country Status (26)

Country Link
US (1) US6867192B1 (tr)
EP (1) EP1140837B1 (tr)
JP (1) JP4431282B2 (tr)
KR (1) KR20010101258A (tr)
CN (1) CN1330637A (tr)
AR (1) AR023727A1 (tr)
AT (1) ATE273954T1 (tr)
AU (1) AU760169B2 (tr)
BR (1) BR9916282A (tr)
CA (1) CA2355630A1 (tr)
CO (1) CO5170533A1 (tr)
CZ (1) CZ20012209A3 (tr)
DE (1) DE69919580T2 (tr)
ES (1) ES2226488T3 (tr)
GB (1) GB9828074D0 (tr)
GT (1) GT199900217A (tr)
HK (1) HK1038744A1 (tr)
HU (1) HUP0104867A3 (tr)
IL (1) IL142908A0 (tr)
NO (1) NO20012995L (tr)
NZ (1) NZ511478A (tr)
PE (1) PE20001387A1 (tr)
PL (1) PL348059A1 (tr)
TR (1) TR200101709T2 (tr)
WO (1) WO2000037444A1 (tr)
ZA (1) ZA200103948B (tr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200200372A (et) 1999-12-28 2003-12-15 Pfizer Products Inc. VLA-4 sõltuva raku seostumise mittepeptiidsed inhibiitorid, mis on kasutatavad põletiku-, autoimmuun- ja respiratoorsete haiguste raviks
GB0014883D0 (en) * 2000-06-16 2000-08-09 Glaxo Group Ltd Novel pharmaceutical formulation
GB0014851D0 (en) * 2000-06-16 2000-08-09 Glaxo Group Ltd Novel pharmaceutical formulation
GB0014947D0 (en) * 2000-06-16 2000-08-09 Glaxo Group Ltd Novel pharmaceutical formulation
GB0014849D0 (en) * 2000-06-16 2000-08-09 Glaxo Group Ltd Pharmaceutical aerosol formulation
GB0014869D0 (en) * 2000-06-16 2000-08-09 Glaxo Group Ltd Novel pharmaceutical formulation
GB0014881D0 (en) * 2000-06-16 2000-08-09 Glaxo Group Ltd Pharmaceutical aerosol formulation
GB0014892D0 (en) * 2000-06-16 2000-08-09 Glaxo Group Ltd Novel pharmaceutical formulation
GB0127423D0 (en) * 2001-11-15 2002-01-09 Glaxo Group Ltd Process
GB0218630D0 (en) 2002-08-10 2002-09-18 Tanabe Seiyaku Co Novel compounds
EP1633731A2 (en) 2003-05-20 2006-03-15 Genentech, Inc. Thiocarbamate inhibitors of alpha-4 integrins
ZA200610158B (en) 2004-06-04 2008-07-30 Genentech Inc Method for treating multiple sclerosis
US8482496B2 (en) 2006-01-06 2013-07-09 Pixtronix, Inc. Circuits for controlling MEMS display apparatus on a transparent substrate
US7999994B2 (en) 2005-02-23 2011-08-16 Pixtronix, Inc. Display apparatus and methods for manufacture thereof
US9082353B2 (en) 2010-01-05 2015-07-14 Pixtronix, Inc. Circuits for controlling display apparatus
US9229222B2 (en) 2005-02-23 2016-01-05 Pixtronix, Inc. Alignment methods in fluid-filled MEMS displays
US20070205969A1 (en) 2005-02-23 2007-09-06 Pixtronix, Incorporated Direct-view MEMS display devices and methods for generating images thereon
US8519945B2 (en) 2006-01-06 2013-08-27 Pixtronix, Inc. Circuits for controlling display apparatus
US8159428B2 (en) 2005-02-23 2012-04-17 Pixtronix, Inc. Display methods and apparatus
US9261694B2 (en) 2005-02-23 2016-02-16 Pixtronix, Inc. Display apparatus and methods for manufacture thereof
US8310442B2 (en) 2005-02-23 2012-11-13 Pixtronix, Inc. Circuits for controlling display apparatus
US9158106B2 (en) 2005-02-23 2015-10-13 Pixtronix, Inc. Display methods and apparatus
US7742016B2 (en) 2005-02-23 2010-06-22 Pixtronix, Incorporated Display methods and apparatus
MY149159A (en) 2005-11-15 2013-07-31 Hoffmann La Roche Method for treating joint damage
US8526096B2 (en) 2006-02-23 2013-09-03 Pixtronix, Inc. Mechanical light modulators with stressed beams
US9176318B2 (en) * 2007-05-18 2015-11-03 Pixtronix, Inc. Methods for manufacturing fluid-filled MEMS displays
US8520285B2 (en) 2008-08-04 2013-08-27 Pixtronix, Inc. Methods for manufacturing cold seal fluid-filled display apparatus
TW201014605A (en) 2008-09-16 2010-04-16 Genentech Inc Methods for treating progressive multiple sclerosis
US8169679B2 (en) 2008-10-27 2012-05-01 Pixtronix, Inc. MEMS anchors
WO2010075249A2 (en) 2008-12-22 2010-07-01 Genentech, Inc. A method for treating rheumatoid arthritis with b-cell antagonists
CN104916258B (zh) 2010-02-02 2018-02-16 追踪有限公司 用于控制显示装置的电路
WO2013101771A2 (en) 2011-12-30 2013-07-04 Genentech, Inc. Compositions and method for treating autoimmune diseases
EP2809684A1 (en) 2012-01-31 2014-12-10 Genentech, Inc. Anti-ig-e m1' antibodies and methods using same
US9134552B2 (en) 2013-03-13 2015-09-15 Pixtronix, Inc. Display apparatus with narrow gap electrostatic actuators
US10100012B2 (en) * 2014-05-30 2018-10-16 Sphaera Pharma Pvt. Ltd. Compounds as anti-tubercular agents
MX385229B (es) * 2015-07-08 2025-03-14 Axerovision Inc Composiciones farmaceuticas que comprenden un antagonista de integrina alfa4 para uso en el tratamiento de condiciones inflamatorias oculares.
PT3359572T (pt) 2015-10-06 2025-01-27 H Hoffnabb La Roche Ag Método para o tratamento da esclerose múltipla
SMT202200173T1 (it) * 2016-06-01 2022-05-12 Athira Pharma Inc Composti
CN109722455B (zh) * 2017-10-31 2022-03-11 中国科学院天津工业生物技术研究所 微生物发酵生产谷内酯的方法、工程菌及应用
WO2019246455A1 (en) 2018-06-20 2019-12-26 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an integrin inhibitor
JP7189368B2 (ja) 2018-10-30 2022-12-13 ギリアード サイエンシーズ， インコーポレイテッド アルファ４ベータ７インテグリンの阻害のための化合物
JP7189369B2 (ja) 2018-10-30 2022-12-13 ギリアード サイエンシーズ， インコーポレイテッド アルファ４β７インテグリンの阻害のための化合物
WO2020092394A1 (en) 2018-10-30 2020-05-07 Gilead Sciences, Inc. Imidazopyridine derivatives as alpha4beta7 integrin inhibitors
CN119462635A (zh) 2018-10-30 2025-02-18 吉利德科学公司 作为α4β7整合素抑制剂的喹啉衍生物
KR20220047323A (ko) 2019-08-14 2022-04-15 길리애드 사이언시즈, 인코포레이티드 알파 4 베타 7 인테그린의 저해용 화합물
CN116670116A (zh) * 2020-10-21 2023-08-29 阿祖拉眼科有限公司 用于治疗眼部病症的化合物和方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1593858A1 (de) 1967-03-02 1970-10-29 Hoechst Ag Verfahren zur Herstellung tyrosinhaltiger Peptide und deren Derivaten
US4105602A (en) * 1975-02-10 1978-08-08 Armour Pharmaceutical Company Synthesis of peptides with parathyroid hormone activity
US6248713B1 (en) 1995-07-11 2001-06-19 Biogen, Inc. Cell adhesion inhibitors
ES2257808T3 (es) 1997-05-29 2006-08-01 MERCK & CO., INC. (A NEW JERSEY CORP.) Acidos biarilalcanoicos como inhibidores de adhesion celular.
CA2291778A1 (en) * 1997-05-29 1998-12-03 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
JP2002501537A (ja) 1997-05-29 2002-01-15 メルク エンド カンパニー インコーポレーテッド 細胞接着阻害薬としてのスルホンアミド類
ATE256699T1 (de) * 1997-05-30 2004-01-15 Celltech Therapeutics Ltd Entzündungshemmende tyrosin-derivate

Also Published As

Publication number Publication date
DE69919580D1 (de) 2004-09-23
JP4431282B2 (ja) 2010-03-10
CZ20012209A3 (cs) 2001-09-12
WO2000037444A1 (en) 2000-06-29
EP1140837B1 (en) 2004-08-18
EP1140837A1 (en) 2001-10-10
GT199900217A (es) 2001-06-09
NZ511478A (en) 2003-08-29
PL348059A1 (en) 2002-05-06
CO5170533A1 (es) 2002-06-27
GB9828074D0 (en) 1999-02-17
ATE273954T1 (de) 2004-09-15
US6867192B1 (en) 2005-03-15
HUP0104867A3 (en) 2002-06-28
ZA200103948B (en) 2002-11-15
JP2002533326A (ja) 2002-10-08
IL142908A0 (en) 2002-04-21
AU3039100A (en) 2000-07-12
HK1038744A1 (zh) 2002-03-28
HUP0104867A2 (hu) 2002-04-29
PE20001387A1 (es) 2000-12-22
NO20012995D0 (no) 2001-06-15
ES2226488T3 (es) 2005-03-16
NO20012995L (no) 2001-08-15
BR9916282A (pt) 2001-10-02
AU760169B2 (en) 2003-05-08
DE69919580T2 (de) 2005-09-01
CA2355630A1 (en) 2000-06-29
AR023727A1 (es) 2002-09-04
KR20010101258A (ko) 2001-11-14
CN1330637A (zh) 2002-01-09

Similar Documents

Publication Publication Date Title
TR200101709T2 (tr) İltihabik hastalıkların tedavisinde yararlı olan bileşikler
TR199901905T2 (tr) 2-(Pürin-9-il)-tetrahidrofuran-3,4-diol türevleri.
TR200100410T2 (tr) 2-(purin-9-il)-tetrahidrofuran-3,4-diol türevleri.
GB9813540D0 (en) Chemical compounds
TR199901305T2 (tr) Calpain-önleyicileri olarak ketonbenzamidler
TR200101567T2 (tr) Yeni triazolo(4.5-D)pirimidin bileşimleri.
AP2000001881A0 (en) 2-(Purine-9-YL)-tetrahydrofuran-3,4 4-diol derivatives.
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
DE60236600D1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
ATE309237T1 (de) Aromatische heterozyklische verbindungen als antientzündungwirkstoffe
TR199900856T2 (tr) Bronsla ilgili terapi maddeleri olarak benzonaftiridinler
MY121294A (en) Novel hexanoic acid derivatives.
TR200100238T2 (tr) Yeni sübstitüe edilmiş pirazol türevleri
TR200003011T2 (tr) Yeni dihidropirimidinler.
DK1200418T3 (da) Nematodicide trifluorbutener
TR200102800T2 (tr) Yeni bileşikler.
TR200100448T2 (tr) Fenil ksantin türevleri
ES2243579T3 (es) Derivados de pirazolopirideno.
SE9804212D0 (sv) Compounds
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
TR200101978T2 (tr) 3,3-Biarilpiperidin ve 2,2-biarilmorfolin türevleri.
TR200000907T2 (tr) Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
TR199802042T2 (tr) Yeni karbon asidi türevleri, üretimleri ve kullanimlari.
DE60225155D1 (de) 3-substituierte 6,7-dihydroxytetrahydroisochinolin-derivate zur verwendung als antibkaterielle mittel